The global market for Prostate Cancer Therapeutics was valued at US$ 1170 million in the year 2024 and is projected to reach a revised size of US$ 1940 million by 2031, growing at a CAGR of 7.6% during the forecast period.

Prostate Cancer Therapeutics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Therapeutics.

The Prostate Cancer Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostate Cancer Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Sale Channel, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prostate Cancer Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channel, and by regions.

Market Segmentation

Scope of Prostate Cancer Therapeutics Market Report

Report Metric	Details
Report Name	Prostate Cancer Therapeutics Market
Accounted market size in year	US$ 1170 million
Forecasted market size in 2031	US$ 1940 million
CAGR	7.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Drugs Medical Devices
Segment by Sale Channel	Hospital Pharmacy Retail Pharmacy Online Sales
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Pfizer, Amgen, Johnson & Johnson, AstraZeneca, AbbVie, Bayer, Ipsen Group, Endo Pharmaceuticals, Dendreon Corporation(Sanpower Group Co. Ltd.)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Sale Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Prostate Cancer Therapeutics Market growing?

Ans: The Prostate Cancer Therapeutics Market witnessing a CAGR of 7.6% during the forecast period 2025-2031.

What is the Prostate Cancer Therapeutics Market size in 2031?

Ans: The Prostate Cancer Therapeutics Market size in 2031 will be US$ 1940 million.

Who are the main players in the Prostate Cancer Therapeutics Market report?

Ans: The main players in the Prostate Cancer Therapeutics Market are Sanofi, Pfizer, Amgen, Johnson & Johnson, AstraZeneca, AbbVie, Bayer, Ipsen Group, Endo Pharmaceuticals, Dendreon Corporation(Sanpower Group Co. Ltd.)

What are the Type segmentation covered in the Prostate Cancer Therapeutics Market report?

Ans: The Types covered in the Prostate Cancer Therapeutics Market report are Drugs, Medical Devices

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Prostate Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Drugs

1.2.3 Medical Devices

1.3 Market by Sale Channel

1.3.1 Global Prostate Cancer Therapeutics Market Growth by Sale Channel: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Sales

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Prostate Cancer Therapeutics Market Perspective (2020-2031)

2.2 Global Prostate Cancer Therapeutics Growth Trends by Region

2.2.1 Global Prostate Cancer Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Prostate Cancer Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Prostate Cancer Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Prostate Cancer Therapeutics Market Dynamics

2.3.1 Prostate Cancer Therapeutics Industry Trends

2.3.2 Prostate Cancer Therapeutics Market Drivers

2.3.3 Prostate Cancer Therapeutics Market Challenges

2.3.4 Prostate Cancer Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Prostate Cancer Therapeutics Players by Revenue

3.1.1 Global Top Prostate Cancer Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Prostate Cancer Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Prostate Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Prostate Cancer Therapeutics Revenue

3.4 Global Prostate Cancer Therapeutics Market Concentration Ratio

3.4.1 Global Prostate Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Therapeutics Revenue in 2024

3.5 Global Key Players of Prostate Cancer Therapeutics Head office and Area Served

3.6 Global Key Players of Prostate Cancer Therapeutics, Product and Application

3.7 Global Key Players of Prostate Cancer Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Therapeutics Breakdown Data by Type

4.1 Global Prostate Cancer Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Prostate Cancer Therapeutics Forecasted Market Size by Type (2026-2031)

5 Prostate Cancer Therapeutics Breakdown Data by Sale Channel

5.1 Global Prostate Cancer Therapeutics Historic Market Size by Sale Channel (2020-2025)

5.2 Global Prostate Cancer Therapeutics Forecasted Market Size by Sale Channel (2026-2031)

6 North America

6.1 North America Prostate Cancer Therapeutics Market Size (2020-2031)

6.2 North America Prostate Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Prostate Cancer Therapeutics Market Size by Country (2020-2025)

6.4 North America Prostate Cancer Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Prostate Cancer Therapeutics Market Size (2020-2031)

7.2 Europe Prostate Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Prostate Cancer Therapeutics Market Size by Country (2020-2025)

7.4 Europe Prostate Cancer Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Prostate Cancer Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Prostate Cancer Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Prostate Cancer Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Prostate Cancer Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Prostate Cancer Therapeutics Market Size (2020-2031)

9.2 Latin America Prostate Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Prostate Cancer Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Prostate Cancer Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Prostate Cancer Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Prostate Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Prostate Cancer Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Prostate Cancer Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Prostate Cancer Therapeutics Introduction

11.1.4 Sanofi Revenue in Prostate Cancer Therapeutics Business (2020-2025)

11.1.5 Sanofi Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Prostate Cancer Therapeutics Introduction

11.2.4 Pfizer Revenue in Prostate Cancer Therapeutics Business (2020-2025)

11.2.5 Pfizer Recent Development

11.3 Amgen

11.3.1 Amgen Company Details

11.3.2 Amgen Business Overview

11.3.3 Amgen Prostate Cancer Therapeutics Introduction

11.3.4 Amgen Revenue in Prostate Cancer Therapeutics Business (2020-2025)

11.3.5 Amgen Recent Development

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Details

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Prostate Cancer Therapeutics Introduction

11.4.4 Johnson & Johnson Revenue in Prostate Cancer Therapeutics Business (2020-2025)

11.4.5 Johnson & Johnson Recent Development

11.5 AstraZeneca

11.5.1 AstraZeneca Company Details

11.5.2 AstraZeneca Business Overview

11.5.3 AstraZeneca Prostate Cancer Therapeutics Introduction

11.5.4 AstraZeneca Revenue in Prostate Cancer Therapeutics Business (2020-2025)

11.5.5 AstraZeneca Recent Development

11.6 AbbVie

11.6.1 AbbVie Company Details

11.6.2 AbbVie Business Overview

11.6.3 AbbVie Prostate Cancer Therapeutics Introduction

11.6.4 AbbVie Revenue in Prostate Cancer Therapeutics Business (2020-2025)

11.6.5 AbbVie Recent Development

11.7 Bayer

11.7.1 Bayer Company Details

11.7.2 Bayer Business Overview

11.7.3 Bayer Prostate Cancer Therapeutics Introduction

11.7.4 Bayer Revenue in Prostate Cancer Therapeutics Business (2020-2025)

11.7.5 Bayer Recent Development

11.8 Ipsen Group

11.8.1 Ipsen Group Company Details

11.8.2 Ipsen Group Business Overview

11.8.3 Ipsen Group Prostate Cancer Therapeutics Introduction

11.8.4 Ipsen Group Revenue in Prostate Cancer Therapeutics Business (2020-2025)

11.8.5 Ipsen Group Recent Development

11.9 Endo Pharmaceuticals

11.9.1 Endo Pharmaceuticals Company Details

11.9.2 Endo Pharmaceuticals Business Overview

11.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Introduction

11.9.4 Endo Pharmaceuticals Revenue in Prostate Cancer Therapeutics Business (2020-2025)

11.9.5 Endo Pharmaceuticals Recent Development

11.10 Dendreon Corporation(Sanpower Group Co. Ltd.)

11.10.1 Dendreon Corporation(Sanpower Group Co. Ltd.) Company Details

11.10.2 Dendreon Corporation(Sanpower Group Co. Ltd.) Business Overview

11.10.3 Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Introduction

11.10.4 Dendreon Corporation(Sanpower Group Co. Ltd.) Revenue in Prostate Cancer Therapeutics Business (2020-2025)

11.10.5 Dendreon Corporation(Sanpower Group Co. Ltd.) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Dendreon Corporation(Sanpower Group Co. Ltd.)

List of Tables

Table 1. Global Prostate Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Drugs

Table 3. Key Players of Medical Devices

Table 4. Global Prostate Cancer Therapeutics Market Size Growth by Sale Channel (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Prostate Cancer Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Prostate Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Prostate Cancer Therapeutics Market Share by Region (2020-2025)

Table 8. Global Prostate Cancer Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Prostate Cancer Therapeutics Market Share by Region (2026-2031)

Table 10. Prostate Cancer Therapeutics Market Trends

Table 11. Prostate Cancer Therapeutics Market Drivers

Table 12. Prostate Cancer Therapeutics Market Challenges

Table 13. Prostate Cancer Therapeutics Market Restraints

Table 14. Global Prostate Cancer Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Prostate Cancer Therapeutics Market Share by Players (2020-2025)

Table 16. Global Top Prostate Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Therapeutics as of 2024)

Table 17. Ranking of Global Top Prostate Cancer Therapeutics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Prostate Cancer Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Prostate Cancer Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Prostate Cancer Therapeutics, Product and Application

Table 21. Global Key Players of Prostate Cancer Therapeutics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Prostate Cancer Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Prostate Cancer Therapeutics Revenue Market Share by Type (2020-2025)

Table 25. Global Prostate Cancer Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Prostate Cancer Therapeutics Revenue Market Share by Type (2026-2031)

Table 27. Global Prostate Cancer Therapeutics Market Size by Sale Channel (2020-2025) & (US$ Million)

Table 28. Global Prostate Cancer Therapeutics Revenue Market Share by Sale Channel (2020-2025)

Table 29. Global Prostate Cancer Therapeutics Forecasted Market Size by Sale Channel (2026-2031) & (US$ Million)

Table 30. Global Prostate Cancer Therapeutics Revenue Market Share by Sale Channel (2026-2031)

Table 31. North America Prostate Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Prostate Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Prostate Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Prostate Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Prostate Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Prostate Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Prostate Cancer Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Prostate Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Prostate Cancer Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Prostate Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Prostate Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Prostate Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Prostate Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Prostate Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Prostate Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Sanofi Company Details

Table 47. Sanofi Business Overview

Table 48. Sanofi Prostate Cancer Therapeutics Product

Table 49. Sanofi Revenue in Prostate Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 50. Sanofi Recent Development

Table 51. Pfizer Company Details

Table 52. Pfizer Business Overview

Table 53. Pfizer Prostate Cancer Therapeutics Product

Table 54. Pfizer Revenue in Prostate Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 55. Pfizer Recent Development

Table 56. Amgen Company Details

Table 57. Amgen Business Overview

Table 58. Amgen Prostate Cancer Therapeutics Product

Table 59. Amgen Revenue in Prostate Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 60. Amgen Recent Development

Table 61. Johnson & Johnson Company Details

Table 62. Johnson & Johnson Business Overview

Table 63. Johnson & Johnson Prostate Cancer Therapeutics Product

Table 64. Johnson & Johnson Revenue in Prostate Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 65. Johnson & Johnson Recent Development

Table 66. AstraZeneca Company Details

Table 67. AstraZeneca Business Overview

Table 68. AstraZeneca Prostate Cancer Therapeutics Product

Table 69. AstraZeneca Revenue in Prostate Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 70. AstraZeneca Recent Development

Table 71. AbbVie Company Details

Table 72. AbbVie Business Overview

Table 73. AbbVie Prostate Cancer Therapeutics Product

Table 74. AbbVie Revenue in Prostate Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 75. AbbVie Recent Development

Table 76. Bayer Company Details

Table 77. Bayer Business Overview

Table 78. Bayer Prostate Cancer Therapeutics Product

Table 79. Bayer Revenue in Prostate Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 80. Bayer Recent Development

Table 81. Ipsen Group Company Details

Table 82. Ipsen Group Business Overview

Table 83. Ipsen Group Prostate Cancer Therapeutics Product

Table 84. Ipsen Group Revenue in Prostate Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 85. Ipsen Group Recent Development

Table 86. Endo Pharmaceuticals Company Details

Table 87. Endo Pharmaceuticals Business Overview

Table 88. Endo Pharmaceuticals Prostate Cancer Therapeutics Product

Table 89. Endo Pharmaceuticals Revenue in Prostate Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 90. Endo Pharmaceuticals Recent Development

Table 91. Dendreon Corporation(Sanpower Group Co. Ltd.) Company Details

Table 92. Dendreon Corporation(Sanpower Group Co. Ltd.) Business Overview

Table 93. Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Product

Table 94. Dendreon Corporation(Sanpower Group Co. Ltd.) Revenue in Prostate Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 95. Dendreon Corporation(Sanpower Group Co. Ltd.) Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Prostate Cancer Therapeutics Picture

Figure 2. Global Prostate Cancer Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Prostate Cancer Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Drugs Features

Figure 5. Medical Devices Features

Figure 6. Global Prostate Cancer Therapeutics Market Size by Sale Channel (2020-2031) & (US$ Million)

Figure 7. Global Prostate Cancer Therapeutics Market Share by Sale Channel: 2024 VS 2031

Figure 8. Hospital Pharmacy Case Studies

Figure 9. Retail Pharmacy Case Studies

Figure 10. Online Sales Case Studies

Figure 11. Prostate Cancer Therapeutics Report Years Considered

Figure 12. Global Prostate Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Prostate Cancer Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Prostate Cancer Therapeutics Market Share by Region: 2024 VS 2031

Figure 15. Global Prostate Cancer Therapeutics Market Share by Players in 2024

Figure 16. Global Top Prostate Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Therapeutics as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Prostate Cancer Therapeutics Revenue in 2024

Figure 18. North America Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Prostate Cancer Therapeutics Market Share by Country (2020-2031)

Figure 20. United States Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Prostate Cancer Therapeutics Market Share by Country (2020-2031)

Figure 24. Germany Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Prostate Cancer Therapeutics Market Share by Region (2020-2031)

Figure 32. China Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Prostate Cancer Therapeutics Market Share by Country (2020-2031)

Figure 40. Mexico Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Prostate Cancer Therapeutics Market Share by Country (2020-2031)

Figure 44. Turkey Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Prostate Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Sanofi Revenue Growth Rate in Prostate Cancer Therapeutics Business (2020-2025)

Figure 48. Pfizer Revenue Growth Rate in Prostate Cancer Therapeutics Business (2020-2025)

Figure 49. Amgen Revenue Growth Rate in Prostate Cancer Therapeutics Business (2020-2025)

Figure 50. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Therapeutics Business (2020-2025)

Figure 51. AstraZeneca Revenue Growth Rate in Prostate Cancer Therapeutics Business (2020-2025)

Figure 52. AbbVie Revenue Growth Rate in Prostate Cancer Therapeutics Business (2020-2025)

Figure 53. Bayer Revenue Growth Rate in Prostate Cancer Therapeutics Business (2020-2025)

Figure 54. Ipsen Group Revenue Growth Rate in Prostate Cancer Therapeutics Business (2020-2025)

Figure 55. Endo Pharmaceuticals Revenue Growth Rate in Prostate Cancer Therapeutics Business (2020-2025)

Figure 56. Dendreon Corporation(Sanpower Group Co. Ltd.) Revenue Growth Rate in Prostate Cancer Therapeutics Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions